Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
The use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (<b>6a</b&g...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/5/1453 |
id |
doaj-7529e8954a1b49e580b40705eeef27a7 |
---|---|
record_format |
Article |
spelling |
doaj-7529e8954a1b49e580b40705eeef27a72021-03-08T00:02:52ZengMDPI AGMolecules1420-30492021-03-01261453145310.3390/molecules26051453Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis InductionHaoran Wang0Jianhua Wei1Hong Jiang2Ye Zhang3Caina Jiang4Xianli Ma5School of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaThe use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (<b>6a</b>–<b>6c</b>) were synthesized as antitumor agents. Compounds <b>6a</b> and <b>6c</b> exhibited better in vitro antiproliferative activity against seven tumor cell lines than cisplatin, they displayed no evident resistance in the cisplatin-resistant cell line A549/DPP. Importantly, <b>6a </b>effectively inhibited tumor growth in the T-24 xenograft mouse model in comparison with cisplatin. Gel electrophoresis assay indicated that DNA was the potential targets of <b>6a</b> and <b>6c</b>, and the upregulation of p-H2AX confirmed this result. Cell cycle arrest studies demonstrated that <b>6a</b> and <b>6c</b> arrested the cell cycle at G1 phase, accompanied by the upregulation of the expression levels of the antioncogene p27 and the down-regulation of the expression levels of cyclin E. In addition, <b>6a</b> and<b> 6c</b> caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-9, cytochrome c, intracellular Ca<sup>2+</sup> release, reactive oxygen species (ROS) generation and the downregulation of Bcl-2. These mechanistic study results suggested that <b>6a</b> and <b>6c</b> exerted their antitumor activity by inducing DNA damage, and consequently causing G1 stage arrest and the induction of apoptosis.https://www.mdpi.com/1420-3049/26/5/1453dithiocarbamateruthenium polypyridyl complexesantitumor activityDNA damagecell cycle arrestapoptosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Haoran Wang Jianhua Wei Hong Jiang Ye Zhang Caina Jiang Xianli Ma |
spellingShingle |
Haoran Wang Jianhua Wei Hong Jiang Ye Zhang Caina Jiang Xianli Ma Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction Molecules dithiocarbamate ruthenium polypyridyl complexes antitumor activity DNA damage cell cycle arrest apoptosis |
author_facet |
Haoran Wang Jianhua Wei Hong Jiang Ye Zhang Caina Jiang Xianli Ma |
author_sort |
Haoran Wang |
title |
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction |
title_short |
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction |
title_full |
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction |
title_fullStr |
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction |
title_full_unstemmed |
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction |
title_sort |
design, synthesis and pharmacological evaluation of three novel dehydroabietyl piperazine dithiocarbamate ruthenium (ii) polypyridyl complexes as potential antitumor agents: dna damage, cell cycle arrest and apoptosis induction |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2021-03-01 |
description |
The use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (<b>6a</b>–<b>6c</b>) were synthesized as antitumor agents. Compounds <b>6a</b> and <b>6c</b> exhibited better in vitro antiproliferative activity against seven tumor cell lines than cisplatin, they displayed no evident resistance in the cisplatin-resistant cell line A549/DPP. Importantly, <b>6a </b>effectively inhibited tumor growth in the T-24 xenograft mouse model in comparison with cisplatin. Gel electrophoresis assay indicated that DNA was the potential targets of <b>6a</b> and <b>6c</b>, and the upregulation of p-H2AX confirmed this result. Cell cycle arrest studies demonstrated that <b>6a</b> and <b>6c</b> arrested the cell cycle at G1 phase, accompanied by the upregulation of the expression levels of the antioncogene p27 and the down-regulation of the expression levels of cyclin E. In addition, <b>6a</b> and<b> 6c</b> caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-9, cytochrome c, intracellular Ca<sup>2+</sup> release, reactive oxygen species (ROS) generation and the downregulation of Bcl-2. These mechanistic study results suggested that <b>6a</b> and <b>6c</b> exerted their antitumor activity by inducing DNA damage, and consequently causing G1 stage arrest and the induction of apoptosis. |
topic |
dithiocarbamate ruthenium polypyridyl complexes antitumor activity DNA damage cell cycle arrest apoptosis |
url |
https://www.mdpi.com/1420-3049/26/5/1453 |
work_keys_str_mv |
AT haoranwang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction AT jianhuawei designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction AT hongjiang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction AT yezhang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction AT cainajiang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction AT xianlima designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction |
_version_ |
1724229197635780608 |